Viewing Study NCT04828395


Ignite Creation Date: 2025-12-24 @ 1:37 PM
Ignite Modification Date: 2025-12-29 @ 11:36 AM
Study NCT ID: NCT04828395
Status: UNKNOWN
Last Update Posted: 2021-05-11
First Post: 2021-03-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Fluzoparib Combined With Camrelizumab for Maintenance Treatment of Locally Advanced Non-small Cell Lung Cancer
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module